DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1747-1759

  Sundaram, Kumaran ^a   Mani, Santhosh K ^b   Kitatani, Kazuyuki ^c   Wu, Kongming ^d   Pestell, Richard G ^d   Reddy, Sakamuri V ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

DACH1; FGF 2; HSF 2; NCoR; Rank ligand

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEAT SHOCK PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR;

ARTICLE; CONFOCAL MICROSCOPY; DROSOPHILA DACHSHUND GENE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL; WESTERN BLOTTING;

BONE MARROW CELLS; CELLS, CULTURED; EYE PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GENES, REPORTER; HEAT-SHOCK PROTEINS; HUMANS; LUCIFERASES; MESENCHYMAL STEM CELLS; OSTEOBLASTS; PROMOTER REGIONS (GENETICS); RANK LIGAND; STROMAL CELLS; TRANSCRIPTION FACTORS;

DROSOPHILA DACHSHUND;

EID: 41849147180     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21561     Document Type: Article

References (40)

1. Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ. 2005. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280:17497-17506.
2. Christians ES, Zhou Q, Renard J, Benjamin IJ. 2003. Heat shock proteins in mammalian development. Semin Cell Dev Biol 14:283-290.
3. Conde R, Xavier J, McLoughlin C, Chinkers M, Ovsenek N. 2005. Protein phosphatase 5 is a negative modulator of heat shock factor 1. J Biol Chem 280:28989-28996.
4. Davis RJ, Shen W, Sandler YI, Amoui M, Purcell P, Maas R, Ou CN, Vogel H, Beaudet AL, Mardon G. 2001. Dach1 mutant mice bear no gross abnormalities in eye, limb, and brain development and exhibit postnatal lethality. Mol Cell Biol 21:1484-1490.
5. Fu Q, Manolagas SC, O'Brien CA. 2006. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol 26:6453-6468.
6. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P. 2002. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233.
7. Horner A, Shum L, Ayres JA, Nonaka K, Nuckolls GH. 2002. Fibroblast growth factor signaling regulates Dach1 expression during skeletal development. Dev Dyn 225:35-45.
8. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545.
9. Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J. 1998. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22:309-316.
10. Kajiya H, Ito M, Ohshima H, Kenmotsu S, Ries WL, Benjamin IJ, Reddy SV. 2006. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells. J Cell Biochem 97:1362-1369.
11. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166:3574-3579.
12. Kim S, Yamazaki M, Zella LA, Shevde NK, Pike JW. 2006. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol Cell Biol 26:6469-6486.
13. Kitazawa R, Kitazawa S, Maeda S. 1999. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1445:134-141.
14. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
15. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
16. Lee SK, Kalinowski J, Jastrzebski S, Lorenzo JA. 2002. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. J Immunol 169:2374-2380.
17. Liu J, Yang H, Liu W, Cao X, Feng X. 2005. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem 96:716-727.
18. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C. 2005. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol 168:1065-1076.
19. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. 1997. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138:4456-4462.
20. Mathew A, Mathur SK, Morimoto RI. 1998. Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway. Mol Cell Biol 18:5091-5098.
21. Menaa C, Reddy SV, Kurihara N, Maeda H, Anderson D, Cundy T, Cornish J, Singer FR, Bruder JM, Roodman GD. 2000. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest 105:1833-1838.
22. Mills BG, Frausto A. 1997. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone. Calcif Tissue Int 61:16-21.
23. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
24. Nakagawa N, Yasuda H, Yano K, Mochizuki S, Kobayashi N, Fujimoto H, Shima N, Morinaga T, Chikazu D, Kawaguchi H, Higashio K. 1999. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. Biochem Biophys Res Commun 265:158-163.
25. Nakano K, Okada Y, Saito K, Tanaka Y. 2004. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. Arthritis Rheum 50:2450-2458.
26. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H. 2000. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 275:768-775.
27. Neale SD, Smith R, Wass JA, Athanasou NA. 2000. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone 27:409-416.
28. O'Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC. 2002. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 30:453-462.
29. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT. 2001. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1787-1794.
30. Reddy S, Devlin R, Menaa C, Nishimura R, Choi SJ, Dallas M, Yoneda T, Roodman GD. 1998. Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption. J Cell Physiol 177:636-645.
31. Roccisana JL, Kawanabe N, Kajiya H, Koide M, Roodman GD, Reddy SV. 2004. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells. J Biol Chem 279:10500-10507.
32. Rossa C, Ehmann K, Liu M, Patil C, Kirkwood KL. 2006. MKK3/6-p38 MAPK signaling is required for IL-1-beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells. J Interferon Cytokine Res 26:719-729.
33. Roux S, Meignin V, Quillard J, Meduri G, Guiochon-Mantel A, Fermand JP, Milgrom E, Mariette X. 2002. RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. Br J Haematol 117:86-92.
34. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ. 2001. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 81:1461-1497.
35. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV. 2007. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 313:168-178.
36. Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. 2006. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-{beta} signaling in ovarian cancer. Cancer Res 66:8404-8412.
37. Thomas GP, Baker SU, Eisman JA, Gardiner EM. 2001. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170:451-460.
38. Wang R, Zhang L, Zhang X, Moreno J, Celluzzi C, Tondravi M, Shi Y. 2002. Regulation of activation-induced receptor activator of NF-kappaB ligand (RANKL) expression in T cells. Eur J Immunol 32:1090-1098.
39. Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, Cvekl A, Pestell RG. 2003. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. J Biol Chem 278:51673-51684.
40. Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, Russell RG, Cvekl A, Pestell RG. 2006. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 26:7116-7129.